NCT04484675View on ClinicalTrials.gov

Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

PHASE4RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 20, 2023

Primary Completion Date

May 10, 2025

Study Completion Date

May 10, 2025

Conditions
Pulmonary Hypertension Due to Left Heart Disease
Interventions
DRUG

Milrinone inhalation

After induction of anesthesia and stable hemodynamics inhaled milrinone( 1 mg/ml) is initiated and intravenous placebo ( normal saline )infusion are administered

DRUG

Milrinone infusion

After induction of anesthesia and stable hemodynamics inhaled placebo( normal saline) is initiated and intravenous ( 1 mg/ml) (0.5 μg/kg/min)infusion are administered

Trial Locations (1)

44519

RECRUITING

Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV